Hjem › Hidradenitis suppurativa › Michigan
Hidradenitis suppurativa kliniske forsøg i Michigan
6 studier for Hidradenitis suppurativa søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Canton
RekruttererFase 2
Alder 18 til 79 · Alle køn · Opdateret 24. sep. 2026 · NCT07783542Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US061, Ann Arbor
- Investigative Site US120, Detroit
- Investigative Site US091, Troy
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Oakland Hills Dermatology Pc, Auburn Hills
- Wayne State University Physician Group Dermatology, Detroit
- Revival Research Institute, Llc Troy, Troy
RekruttererFase 2
Alder 12 til 17 · Alle køn · Opdateret 6. aug. 2026 · NCT07213973A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Wayne State University, Detroit
- Hamzavi Dermatology, Fort Gratiot
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 6. mar. 2026 · NCT07244263A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- University of Michigan Health System - Ann Arbor /ID# 267275, Ann Arbor
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 24. jan. 2025 · NCT06524635Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
- WSUPG Dermatology, Dearborn
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 16. maj 2023 · NCT04218422Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.